Frédéric Joël Desdouits
Director Ejecutivo en TreeFrog Therapeutics SAS .
Origen de la red de primer grado Frédéric Joël Desdouits.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
12
| Public Company | Biotechnology | 12 |
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
TreeFrog Therapeutics SAS
 TreeFrog Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services TreeFrog Therapeutics SAS provides stem cell treatment services. It offers its expertise to patients of heart failure, diabetes, traumatic injury, skin burns, dermatitis, Huntington, and Parkinson disease. The company was founded by Maxime Feyeux, Kevin Alessandri, Jean-Luc Treillou, Erwan Bezard, Laurent Cognet, and Pierre Nassoy and is headquartered in Pessac, France.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Orano Med SAS
 Orano Med SAS BiotechnologyHealth Technology Orano Med SAS is a French biotechnology company that utilizes nuclear technology to develop new therapies for cancer patients with resistant forms of cancer. The company is based in Châtillon, France, and the CEO of the company is Julien Dodet. The company specializes in targeted alpha therapy treatments, which combines biological molecules to target cancer cells with the properties of lead-212 (212pb) to destroy them while limiting the impact on surrounding healthy cells. Orano Med has formed collaborations with prestigious institutions and biopharmaceutical companies to develop several treatments using 212pb combined with various targeting agents. The company has 212pb manufacturing facilities, laboratories, and R&D centers in France and the United States and is currently investing to expand its GMP-manufacturing capacities for 212pb radiolabeled pharmaceuticals. Orano Med is ultimately controlled by the Government of France.
7
| Subsidiary | Biotechnology | 7 |
Exonhit
 Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France.
5
| Extinct | Pharmaceuticals: Major | 5 |
2
| Public Company | Chemicals: Major Diversified | 2 |
Bionest Partners SAS
 Bionest Partners SAS Miscellaneous Commercial ServicesCommercial Services Bionest Partners SAS operates as a global consulting firm which focuses on pharma, biotech, medical device and diagnostics. It offers strategy development, product planning and assessment services. The company was founded by Robert J. Easton and Alain J. Gilbert and is headquartered in Paris, France.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Citoxlab France SAS
 Citoxlab France SAS Miscellaneous Commercial ServicesCommercial Services Citoxlab France SAS operates as a research laboratory. It offers services in toxicology, genomics, pharmacology, pharmacokinetics, bio-analysis, ecotoxicology, stability testing and regulatory affairs. The company was founded in 1969 and is headquartered in Miserey, France.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Frédéric Joël Desdouits a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| INSEAD | College/University | Doctorate Degree Undergraduate Degree Masters Business Admin | |
| EUROBIO SCIENTIFIC | Medical Specialties | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ROTHSCHILD & CO | Investment Banks/Brokers | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel Corporate Officer/Principal | |
| ESSEC Business School | College/University | Undergraduate Degree Masters Business Admin | |
Orano Recyclage SAS
 Orano Recyclage SAS Miscellaneous Commercial ServicesCommercial Services Orano Recyclage SAS engages in the production and transformation of nuclear materials. The company is based in La Hague, France. The French company is ultimately controlled by the Government of France. | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
Novartis Pharma SAS
 Novartis Pharma SAS Pharmaceuticals: MajorHealth Technology Novartis Pharma SAS wholesales and distributes pharmaceutical products. It offers generic and branded drugs and medicines. The company is headquartered in Rueil-Malmaison, France. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
| Université de Bordeaux | College/University | Doctorate Degree Doctorate Degree | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal President | |
World Nuclear Association
 World Nuclear Association Miscellaneous Commercial ServicesCommercial Services World Nuclear Association operates an international organization that promotes nuclear power and supports the companies that comprise the global nuclear industry. The company was founded in 1975 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| AREVA | Other Metals/Minerals | Corporate Officer/Principal Chief Executive Officer | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Chief Administrative Officer Corporate Officer/Principal | |
Orano Cycle SA
 Orano Cycle SA Other Metals/MineralsNon-Energy Minerals Orano Cycle SA provides nuclear fuel cycle services. It specializes in uranium mining conversion and enrichment. The company is headquartered in Chatillon, France. | Other Metals/Minerals | Chief Executive Officer Director/Board Member | |
| École Nationale Supérieure de Chimie de Paris | College/University | Undergraduate Degree Director/Board Member | |
| Ecole Polytechnique | College/University | Undergraduate Degree Graduate Degree | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
VLG Chem SASU
 VLG Chem SASU Pharmaceuticals: MajorHealth Technology Part of PCAS SA, VLG Chem SASU is a French company that manufactures pharmaceutical products. The company is based in Villeneuve-la-Garenne, France. The company was founded in 2004. VLG Chem was acquired by PCAS SA from Aventis SA on June 01, 2004. | Pharmaceuticals: Major | Chairman | |
| Union des Industries Chimiques | Director/Board Member | ||
Amylum
 Amylum Agricultural Commodities/MillingProcess Industries Part of Tate & Lyle Plc, Amylum is a Belgian company that manufactures cereal products. The company is based in Aalst, Belgium. Amylum was acquired by Tate & Lyle Plc from Compagnie Industrielle et Financière des Produits Amylaces SA on August 14, 2000 for $428.99 million. | Agricultural Commodities/Milling | Chairman | |
Segula Holding SARL
 Segula Holding SARL Engineering & ConstructionIndustrial Services Segula Holding SARL is a French engineering company. The private company is based in Nanterre, France. | Engineering & Construction | Director/Board Member | |
| Michelin Group | Corporate Officer/Principal | ||
Thea Holding SAS
 Thea Holding SAS Financial ConglomeratesFinance Thea Holding operates as a investment company. The company is headquartered in Clermont-Ferrand, France. | Financial Conglomerates | Director/Board Member | |
| College des Ingenieurs | College/University | Corporate Officer/Principal | |
CardioRenal
 CardioRenal Pharmaceuticals: MajorHealth Technology CardioRenal develops a telemedicine solution for homebound patients with severe heart conditions. It specializes in artificial intelligence and digital health. The firm allows for daily measurements of cardiac biomarkers in a droplet of blood drawn and analyzed by the patients themselves. The company was founded by Faiez Zannad and Patrick Rossignol and is headquartered in Strasbourg, France. | Pharmaceuticals: Major | Director/Board Member | |
Expansia SARL
 Expansia SARL Financial ConglomeratesFinance Expansia SARL provides financial services. The company was founded in 2004 and is headquartered in Caen, France. | Financial Conglomerates | Chairman | |
| PCAS America, Inc. | Chairman | ||
Société Béarnaise de Synthèse SASU
 Société Béarnaise de Synthèse SASU Chemicals: SpecialtyProcess Industries Part of DSM-Firmenich AG, Société Béarnaise de Synthèse SASU is a fine chemicals company based in Dax, France. Société Béarnaise de Synthèse SASU specializes in fine chemicals. The French company was founded in 1996 and was acquired by Les Dérivés Résiniques et Terpéniques SAS, a SUB of DSM-Firmenich AG from Dynaction SA on March 20, 2013. | Chemicals: Specialty | Chairman | |
Melchior Material & Life Science SAS
 Melchior Material & Life Science SAS Pharmaceuticals: MajorHealth Technology Melchior Material & Life Science SAS is engaged in manufacturing pharmaceutical products. Its services encompass cGMP and non-cGMP, chemical and analytical development of syntheses, custom manufacturing of drug substance and advanced intermediates, analytical chemistry, and scale up synthesis. The company was founded in 2012 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Boost Neuroscience, Inc.
 Boost Neuroscience, Inc. Miscellaneous Commercial ServicesCommercial Services Boost Neuroscience, Inc. is an American company that focuses on researching and developing therapies for age-related cognitive deficits. The CEO of the company is Matthew P. Pando. | Miscellaneous Commercial Services | Chief Executive Officer | |
Recognify Life Sciences, Inc.
 Recognify Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Recognify Life Sciences, Inc. develops treatments for cognitive impairment associated with schizophrenia. The company is based in Brisbane, CA. The company was founded by Thomas C. Südhof, Matthew P. Pando, Kristen Angela MacFarlane, Gary Walker. Matthew P. Pando has been the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer | |
| University of California San Diego | College/University | Doctorate Degree | |
| The Salk Institute for Biological Studies | College/University | Doctorate Degree | |
| Colorado State University | College/University | Undergraduate Degree | |
Conseil Européen de l'industrie Chimique - European Chemical
 Conseil Européen de l'industrie Chimique - European Chemical Wholesale DistributorsDistribution Services Conseil Européen de l'industrie Chimique, also known as the European Chemical Industry Council (Cefic), is a non-profit organization that represents large, medium, and small chemical companies across Europe. The non-profit company was founded in 1972 and is based in Brussels, Belgium, with subsidiaries in Belgium. Cefic is committed to the UN sustainability agenda and has developed a unique roadmap, called the Transition Pathway, to guide the European chemicals industry through the massive transformation needed to meet the EU Green Deal goals. The Transition Pathway lays out more than 200 actions for the EU institutions, Member State governments, and industry to build the business case for investing in sustainability. Cefic provides clarity, predictability, and direction to guide the industry through the transition. | Wholesale Distributors | Director/Board Member | |
| European Fine Chemical Group | Director/Board Member | ||
| Société chimique de France | Director/Board Member | ||
| France Chimie SP | Director/Board Member | ||
| EUROAPI | Biotechnology | Corporate Officer/Principal | |
Protéus SA
 Protéus SA BiotechnologyHealth Technology Protéus SA discovers, engineers, and manufactures proteins for industrial applications. It operates as a biotechnology company that focuses on the discovery, engineering and manufacturing of proteins of industrial interest, and on the development of protein-based bioprocesses. The company was founded on August 11, 1998 and is headquartered in Paris, France. | Biotechnology | Chairman | |
Demeta SAS
 Demeta SAS BiotechnologyHealth Technology Demeta SAS operates as a research and Development in Biotechnology. The firm specializes in biological products, except diagnostic substances. The company was founded in April 4, 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
PCAS Canada, Inc.
 PCAS Canada, Inc. Chemicals: Major DiversifiedProcess Industries PCAS Canada, Inc. manufactures chemical products. It produces chemicals for microelectronics, printed electronics, graphic arts and pharmaceutical industries. The company was founded in 1989 and is headquartered in Saint-Jean-sur-Richelieu, Canada. | Chemicals: Major Diversified | Director/Board Member | |
| Ecole Supérieure de Chimie Organique et Minérale | College/University | Director/Board Member | |
| SICOS Biochimie | Chairman | ||
PCAS-Nanosyn LLC
 PCAS-Nanosyn LLC BiotechnologyHealth Technology PCAS-Nanosyn LLC is a Joint Venture company. It offers cgmp, research & development, analytical, regulatory, chemistry, handling, product & equipment storage and specialty equipment services. The company was founded in 2009 and is headquartered in Santa Rosa, CA. | Biotechnology | Director/Board Member | |
| Dauphin Participations | Director/Board Member | ||
PCAS Finland Oy
 PCAS Finland Oy Chemicals: SpecialtyProcess Industries Part of Seqens SAS, PCAS Finland Oy is a Finnish company that manufactures chemicals and pharmaceutical ingredients. The company is based in Turku, Finland. The company was founded in 2001. Jussi Olavi Torikka has been the CEO of the company since 2004. | Chemicals: Specialty | Chairman |
Estadísticas
Internacional
| Francia | 34 |
| Estados Unidos | 11 |
| Bélgica | 4 |
| Reino Unido | 2 |
| Canadá | 2 |
Sectorial
| Health Technology | 16 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Process Industries | 5 |
| Finance | 4 |
Operativa
| Director/Board Member | 185 |
| Corporate Officer/Principal | 85 |
| Chairman | 47 |
| Chief Executive Officer | 35 |
| Independent Dir/Board Member | 29 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Carole Piwnica | 37 |
| Suet-Fern Lee | 36 |
| Elias Zerhouni | 26 |
| Jean-Michel Petit | 24 |
| Vincent Touraille | 23 |
| Philippe Knoche | 20 |
| Thierry Laugel | 18 |
| Thomas DesRosier | 15 |
| Hervé Duchesne de Lamotte | 15 |
| Luc Etienne Péligry | 14 |
| Wayne Pisano | 14 |
| Laurent Higueret | 14 |
| Didier Miraton | 12 |
| Philippe Rousseau | 12 |
| Loïc Maurel | 12 |
- Bolsa de valores
- Insiders
- Frédéric Joël Desdouits
- Conexiones Empresas